M&A activity bounced back in the second half of the year, with deals ranging from Teladoc's $18.5B Livongo buy to Stryker's drawn-out $4B acquisition of Wright Medical.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,